Topic: Solid Organ Transplant Rejection
1. Identify and understand the role of therapeutic apheresis in desensitization protocols for incompatible solid organ transplants.
2. Understand the role of therapeutic apheresis in the treatment of rejection of solid organ transplants
3. Describe how therapeutic apheresis is currently being used in kidney, heart and lung transplantation
Speaker: Karen King, MD
Dr. King received her medical degree from Johns Hopkins University School of Medicine. She completed residency in anatomic and clinical pathology and fellowship in transfusion medicine at Johns Hopkins. Following fellowship, she joined the faculty at Johns Hopkins where she is currently the Director of Hemapheresis and Transfusion Support (HATS), Associate Director of Transfusion Medicine and Associate Professor of Pathology and Oncology. Dr. King is actively involved in education; she is the co-Director of the Pathology Residency Program and Co-Director of the Transfusion Medicine Fellowship Program. She has expertise in apheresis, immunohematology, transfusion management of patients with sickle cell disease and platelet management for patients with refractoriness. She has worked with the Incompatible Kidney Transplant Program at Johns Hopkins since its inception.